심근 수축기전에 있어서 중심적인 역할을 하는 칼슘 이온과 Hienamine과의 상호작용을 비교 검토하였고 아울러 이 강심효과에 대하여 칼슘길항제인 란타눔과 verapamil을 사용하여 이에 미치는 영향을 관찰하였다. Higenamine은 적출 가토좌심방근에 대해 심근의 칼슘과 상호보완적인 상승 및 상가작용을 나타내었고 Higenamine 10-7g/ml은 0.058mM의 칼슘과 동등한 심근 수축증강효과를 나타내었으며 부자부타놀 분획물과 비교할 때 약 1,000배 정도 강력한 강심작용을 나타내었다. 또한 심근세포막의 칼슘유입을 억제한 조건인 란타눔과 verapamil처치시에도 Higenamine은 용량의존적으로 저하된 심근 수축력을 회복시킴으로 미루어 볼 때 Higenamine외 강심작용기전의 일부는 세포막을 통한 칼슘의 유입을 촉진시키는 것일 것으로 추측하였다.
Higenamine (Ca26H17No3. HCI, d1-1- (4-hydroxybenzyl) -6,7-dihydroxy-1,2,3,4-tetrahydroiso-quinoline hydrochloride), which has recently teen isolated from the Aconite root, was known to the cardiotonic component of the Aconite root. The positive inotropic effect of Higenamine was observed in the isolated electrically driven left atrium from rabbits with respect to the influences of extracellular calcium and of calcium antagonists, e.g. La+++ and verapamil. A synergistic relation in the positive inotropic effect could be demonstrated between Higenamine and extra cellular calcium. The inotropic potency of 10-7 g/ml Higenamine was equivalant to that of 0.058 mM of calcium in the medium. In the preparation, of which contractility had been reduced by the treatment of La+++(10-5-10-4M) and verapamil(2 ×10-7-10-6M), Higenamine was able to restore the contractility. These results indicated that one of the possible mechanism of positive inotropism of Higenamine was to accelerate the influx of calcium from the extracellular space through the sarcolemma.
